AME vs MCRB · P/E 30, rev $2.04B vs rev $1.1M
Ametek Inc (AME) versus Seres Therapeutics Inc (MCRB) — a side-by-side from cached financials, not a winner call.
Ametek Inc (AME) is a specialty industrial machinery company listed on US.
Seres Therapeutics Inc (MCRB) is a biotechnology company listed on US.
Latest reported AME revenue for 2026-06-30 was $2.04B. Net income was $406.9M. Revenue was up 6.0% from 2026-03-31 to 2026-06-30. AME currently screens at market cap $42.11B and trailing P/E 29.9.
Latest reported MCRB revenue for 2026-06-30 was $1.1M. Net income was -$15.3M. MCRB currently screens at market cap $109.8M.
AME currently screens at market cap $42.11B and trailing P/E 29.9. MCRB currently screens at market cap $109.8M.
Not investment advice. Open the AME and MCRB stock pages for the full models.
Not investment advice.